VivoSim Labs, Inc. (VIVS) financial statements and ratios from SEC XBRL: revenue $131000.00 (TTM), net margin -10567.2%, revenue growth -9.0% YoY. Income statement, balance sheet, cash flow, and valuation. First-party data.
| Revenue (TTM) | $131000.00 |
| Net Margin | -10567.2% |
| Return on Equity | 525.9% |
| Current Ratio | 1.70 |
| Revenue Growth (YoY) | -9.0% |
| EPS Growth (YoY) | 214.7% |
| FCF Growth (YoY) | 14.3% |
| EV / EBITDA | -0.2 |
| Price / Book | -1.81 |
| Price / Sales | 37.92 |
| FCF Yield | -238.3% |
| Altman Z-Score | -71.90 (distress) |
| Sector P/E (Healthcare) | 21.7 |
VIVS overview · VIVS earnings · VIVS KPIs · VIVS investor relations · VIVS ownership · VIVS peers · VIVS filings
Data sourced from U.S. SEC EDGAR XBRL filings. Not personalized investment advice.